A consortium made up of 300 hospitals – and counting – are taking a bold step to address high drug prices and shortages of essential medicines: they’re cutting out the pharma middleman and starting their own non-profit generic drug company.
The move is a first of its kind, according to a report from The New York Times. Intermountain Healthcare, a non-profit Salt Lake City, Utah-based hospital is leading the charge.
“This is a shot across the bow of the bad guys,” CEO Dr. Marc Harrison told the news outlet. “We’re not going to lay down. We are going to go ahead and try and fix it.”
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.